$0.73
0.04 (+5.84%)
Alexza Pharmaceuticals, Inc. (NASDAQ:ALXA)
CAPS Rating:
An emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions.
RSS Headlines
Fool UK